Benjamin Shaker - 14 Apr 2024 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Chief Markets Officer
Signature
/s/ Mimi Yang, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
14 Apr 2024
Net transactions value
-$27,255
Form type
4
Filing time
17 Apr 2024, 21:39:04 UTC
Previous filing
18 Mar 2024
Next filing
18 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Award $0 +196,189 +76% $0.000000 454,921 15 Apr 2024 Direct F1, F2
transaction AGL Common Stock Tax liability $27,255 -5,506 -1.2% $4.95 449,415 14 Apr 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Right to buy) Award $0 +322,879 $0.000000 322,879 15 Apr 2024 Common Stock 322,879 $4.46 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units that vest in four equal installments on each anniversary of April 15, 2024, subject to continued employment.
F2 Includes restricted stock units.
F3 Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
F4 Options that vest in four equal installments on each anniversary of April 15, 2024, subject to continued employment.